- Home
- SCOR vs TENX Comparison
SCOR vs TENX Comparison
Compare SCOR & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- TENX
- Stock Information
- Founded
- SCOR 1999
- TENX 1967
- Country
- SCOR United States
- TENX United States
- Employees
- SCOR N/A
- TENX N/A
- Industry
- SCOR Business Services
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- TENX Health Care
- Exchange
- SCOR Nasdaq
- TENX Nasdaq
- Market Cap
- SCOR 23.9M
- TENX 25.8M
- IPO Year
- SCOR 2007
- TENX N/A
- Fundamental
- Price
- SCOR $6.25
- TENX $5.85
- Analyst Decision
- SCOR Buy
- TENX Strong Buy
- Analyst Count
- SCOR 2
- TENX 3
- Target Price
- SCOR $10.75
- TENX $16.00
- AVG Volume (30 Days)
- SCOR 25.1K
- TENX 23.2K
- Earning Date
- SCOR 08-05-2025
- TENX 08-19-2025
- Dividend Yield
- SCOR N/A
- TENX N/A
- EPS Growth
- SCOR N/A
- TENX N/A
- EPS
- SCOR N/A
- TENX N/A
- Revenue
- SCOR $358,513,000.00
- TENX N/A
- Revenue This Year
- SCOR $3.36
- TENX N/A
- Revenue Next Year
- SCOR $2.72
- TENX N/A
- P/E Ratio
- SCOR N/A
- TENX N/A
- Revenue Growth
- SCOR N/A
- TENX N/A
- 52 Week Low
- SCOR $4.39
- TENX $3.25
- 52 Week High
- SCOR $8.99
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- SCOR 57.43
- TENX 40.47
- Support Level
- SCOR $4.81
- TENX $5.80
- Resistance Level
- SCOR $7.23
- TENX $6.25
- Average True Range (ATR)
- SCOR 0.56
- TENX 0.24
- MACD
- SCOR 0.13
- TENX -0.04
- Stochastic Oscillator
- SCOR 59.50
- TENX 10.31
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.